MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202521134563 A) filed by Mit Art, Design And Technology University, Pune, Maharashtra, on Dec. 31, 2025, for 'an artificial intelligence based prediction and management system for gestational diabetes mellitus and method thereof.'
Inventor(s) include Prof. Dr. Reena Gunjan; Prof. Poonam Bhosale.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to an artificial intelligence (AI)-based prediction and management system (100) for Gestational Diabetes Mellitus (GDM). The system (100) comprises a data acquisition module (105) for collecting multi-modal clinical, laboratory, and patient-reported pregnancy data, and a data preprocessing module (110) configured to clean, normalize, and structure the acquired data. A feature engineering module (115) generates clinically relevant predictive variables. A hybrid AI inference module (120) integrates a Gradient Boosting Decision Tree (GBDT) or LightGBM processing engine (121) with a Bayesian Network processing engine (122) to enable high-accuracy prediction with uncertainty modeling. An explainability module (125) provides interpretable outputs using SHAP-based analysis. An output and deployment module (130) generates personalized clinical decision support including early GDM diagnosis indicators, risk scores, alerts, and treatment recommendations in real time. The invention further provides a method (200) enabling accurate, reliable, and transparent GDM risk prediction to support improved maternal healthcare outcomes."
Disclaimer: Curated by HT Syndication.
